Timber Pharmaceuticals Inc. (TMBR)
$0.00
$0.00 (0.00%)As on 31-Jan-2024 09:30EDT
Market cap
$1 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
6.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-3 Mln
-
ROE
-3.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
3,432,740
10 Years Aggregate
CFO
$-99.64 Mln
EBITDA
$-129.73 Mln
Net Profit
$-116.93 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Timber Pharmaceuticals (TMBR)
| 0.0 | 0.0 | -100.0 | -99.9 | -97.3 | -94.0 | -- |
|
BSE Sensex*
| -8.5 | 2.8 | 4.6 | -5.5 | 7.2 | 8.0 | 11.4 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Timber Pharmaceuticals (TMBR)
| -99.9 | -90.8 | -48.9 | -85.4 | -84.3 | -2.1 | -70.5 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Timber Pharmaceuticals (TMBR)
|
0.0 | 1.2 | 0.1 | -15.1 | -17,458.3 | -- | -- | 6.9 |
| 294.1 | 37,128.5 | 4,286.9 | 577.2 | 20.3 | 88.2 | 69.9 | 34.5 | |
| 79.8 | 11,524.9 | 622.0 | -300.9 | -25.7 | -61.1 | -- | 18.7 | |
| 52.9 | 13,047.8 | 2,375.5 | 833.4 | 41.5 | 40.7 | 17.2 | 6.7 | |
| 185.6 | 28,000.8 | 16,632.0 | 1,385.0 | 14.1 | 22.3 | 20.9 | 4.5 | |
| 509.8 | 11,660.4 | 1,132.5 | -309.4 | -25.0 | -52.9 | -- | 21.4 | |
| 512.8 | 13,143.2 | 2,678.3 | 460.4 | 21.3 | 103.2 | 29 | 22.0 | |
| 623.4 | 63,945.5 | 14,919.6 | 4,423.4 | 34.9 | 14.2 | 14.9 | 2.0 | |
| 550.0 | 22,776.5 | 3,169.8 | 1,287.4 | 51.3 | 20.6 | 19.8 | 3.9 | |
| 475.2 | 114,626.1 | 12,255.1 | 4,338.3 | 42.2 | 23.7 | 26.8 | 5.9 |
Shareholding Pattern
View DetailsAbout Timber Pharmaceuticals (TMBR)
Timber Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical... formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-003, a proprietary formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist that is in preclinical development for the treatment of sclerotic skin diseases. It is also involved in the development of BPX-01, which is in Phase 3 topical minocycline for the treatment of inflammatory lesions of acne vulgaris; and BPX-04 that is a Phase 3 ready topical minocycline for the treatment of papulopustular rosacea. The company was founded in 2019 and is headquartered in Warren, New Jersey. On November 17, 2023, Timber Pharmaceuticals, Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Read more
-
Chairman, CEO & Pres
Mr. John Koconis M.B.A.
-
Exec. VP, CFO, Treasurer & Sec.
Mr. Joseph Lucchese
-
Headquarters
Basking Ridge, NJ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Timber Pharmaceuticals (TMBR)
What is the current share price of Timber Pharmaceuticals Inc (TMBR) Today?
The share price of Timber Pharmaceuticals Inc (TMBR) is $0.00 (NYSE) as of 31-Jan-2024 09:30 EDT. Timber Pharmaceuticals Inc (TMBR) has given a return of -97.31% in the last 3 years.
What is the current PB & PE ratio of Timber Pharmaceuticals Inc (TMBR)?
Since, TTM earnings of Timber Pharmaceuticals Inc (TMBR) is negative, P/E ratio is not available.
The P/B ratio of Timber Pharmaceuticals Inc (TMBR) is 6.94 times as on 31-Jan-2024, a 61 premium to its peers’ median range of 4.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
What is the 52 Week High and Low of Timber Pharmaceuticals Inc (TMBR)?
The 52-week high and low of Timber Pharmaceuticals Inc (TMBR) are Rs -- and Rs -- as of 25-Jun-2026.
What is the market cap of Timber Pharmaceuticals Inc (TMBR)?
Timber Pharmaceuticals Inc (TMBR) has a market capitalisation of $ 1 Mln as on 31-Jan-2024. As per SEBI classification, it is a company.
Should I invest in Timber Pharmaceuticals Inc (TMBR)?
Before investing in Timber Pharmaceuticals Inc (TMBR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.